Nordic Randomized Trial on Laparoscopic Versus Vaginal Cerclage
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Laparoscopic cerclage, Vaginal cerclage.
- Кому может быть актуально
- Состояния в реестре: Preterm Birth, Cervical Insufficiency. Базовые параметры: от 18 лет · Женщины.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Дания
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
Every year 15 million babies are born prematurely, which can lead to death or life-long disabilities. It is often caused by a dysfunction of the uterine cervix, which constitutes the narrow channel between the vagina and womb. During pregnancy, this channel must remain closed until the beginning of term labor. A weak cervix may not withstand the weight of the fetus, the amniotic fluid and the placenta and the cervical canal will open and cause late miscarriage or preterm delivery. To prevent this, a band (cerclage) can be applied around the cervix either vaginally or laparoscopically prior to a new pregnancy. To evaluate which treatment is best for most women, we will randomize (allocate by chance) women at risk for preterm birth, to either vaginal cerclage or laparoscopic cerclage in the Nordic countries and England
Подробное описание
Both vaginal and abdominal cerclages are procedures that have been used to prevent preterm birth for more than 50 years. However, only one previous study (MAVRIC, Shennan et al. 2020) has compared the two methods in a randomised trial. Other than evidence from the MAVRIC trial there is uncertainty whether an abdominal cerclage should be preferred over vaginal cerclage, and which women would benefit from it the most.
NORACT is an open, multicenter, superiority, randomized controlled trial with the overall objective to compare laparoscopic versus vaginal cerclage in woman in whom the clinician has equipoise as to whether an elective vaginal or abdominal cerclage will be the best intervention to prevent preterm birth. Participants will be recruited pre-pregnancy or in early pregnancy and randomised to vaginal or laparoscopic cerclage. If randomised to laparoscopic cerclage this will be inserted pre-pregnancy or before 10+0 weeks of gestation. The vaginal cerclage will be inserted during pregnancy, before 16+0 weeks of gestation. A total sample of 188 participants will be included to detect a target difference of 15% in the primary outcome between the two groups. The two primary outcomes are delivery before 32+0 weeks of gestation and baby death. The study extends from sites in Denmark, Sweden, Norway, Finland, Iceland, and the United Kingdom.
Вмешательства
- Процедура Laparoscopic cerclage
Classic or robot-assisted laparoscopic cerclage in non-pregnant or early pregnant women. - Процедура Vaginal cerclage
Transvaginal cerclage in pregnant women.
Первичные конечные точки
- Delivery <32+0 weeks of gestation. [Срок оценки: At birth.]
- Baby death. [Срок оценки: From birth - four weeks after due date. In the first subsequent viable pregnancy beyond 14 weeks of gestation.]
Вторичные конечные точки (12)
- Maternal mortality - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
- Maternal mortality. [Срок оценки: From time of randomisation - 42 days after delivery.]
- Maternal morbidity - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
- Maternal morbidity [Срок оценки: From time of randomisation - 42 days after delivery.]
- Harm to participant - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
- Harm to participant [Срок оценки: From time of cerclage procedure - 42 days after delivery.]
- Bleeding - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
- Bleeding - pregnancy related. [Срок оценки: From time of cerclage procedure - 42 days after delivery.]
- Maternal infection - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
- Maternal infection - pregnancy related. [Срок оценки: From time of cerclage procedure - 42 days after delivery]
- Maternal serious infection - pregnancy related. [Срок оценки: From time of cerclage procedure - 42 days after delivery.]
- Maternal serious infection - surgery related. [Срок оценки: 30 days after insertion of laparoscopic or vaginal cerclage.]
Критерии участия
Критерии включения
- Women in whom the clinician has equipoise as to whether an elective vaginal or abdominal cerclage will be the best intervention to prevent preterm birth.
- Not yet pregnant or <10 weeks' pregnant.
Критерии исключения
- Any circumstance under which the clinician is not willing to randomize is an exclusion criterion.
- Any condition or circumstance under which laparoscopic or vaginal cerclage surgery is contraindicated (i.e. on-going pregnancy of more than 10+0 gestational weeks).
- Language difficulties.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Профилактика
Центры проведения
Дания · 2 центра
- Aarhus University Hospital — Aarhus N
- Rigshospitalet — Copenhagen
Публикации
- Hansen LK, Krogh LQ, Lantto A, Uldbjerg N, Jensen PT, Shennan A, Hald K, Heikinheimo O, Jacobsson B, Hjartardottir H, Karypidis H, Glavind J. Nordic randomised trial on laparoscopic versus vaginal cerclage (NORACT): trial protocol for an international, multicentre, randomised controlled trial. BMJ Open. 2025 Sep 23;15(9):e107093. doi: 10.1136/bmjopen-2025-107093. PMID 40987744
Идентификаторы
NCT: NCT06122506 · 06190 · NNF21OC0071037